Table 4.
nelfinavir | saquinavir | Ref. | |||
---|---|---|---|---|---|
inhibition | conc. | inhibition | conc. | ||
L. amazonensis (MHOM/BR/77/LTB016) |
50% (48h) | 15.12 | Virtually no inhibition1 | [62] | |
L. amazonensis (MHOM/BR/77/LTB016) |
95% (72h) | 25 | 5% | 25 | [106] |
L. amazonenzis (IFLA/BR/67/PH8) |
50% 3 | 13.36 | 50% 3 | 40 | [63] |
L. major (LRC-L137) |
49% (24h) | 6.25 | [59] | ||
L. major (MHOM/SU/73/5-ASKH) |
50% 3 | 13.37 | 50% 3 | 46.95 | [63] |
L. major (MHOM/IL/1980/FRIEDLIN) |
50% (72h) | 25 | 21.2% (72h) | 25 | [106] |
L. infantum (MHM/TN/80/IPT1) |
31% (24h) | 50 | [59] | ||
L. infantum (MHOM/MA/67/ITMAP-263) |
Virtually no inhibition2 | Virtually no inhibition2 | [61] | ||
L. infantum (MHOM/FR/78/LEM-75) |
50% 3 | 16.46 | 50% 3 | 53.97 | [63] |
L. infantum (MCAN/ES/98/LLM-724) |
50% 3 | 17.59 | 50% 3 | 50.87 | [63] |
L. infantum (MCAN/VE/98/IBO-78) |
50% 3 | 14.05 | 50% 3 | 55.12 | [63] |
L. infantum (MHOM/ES/95/LLM-480) |
50% 3 | 18.21 | 50% 3 | 48.04 | [63] |
L. infantum (MHOM/ES/98/LLM-759)4 |
50% 3 | 26.89 | 50% 3 | 64.464 | [63] |
L. infantum (MHOM/BR/1974/PP75) |
96.2% (72h) | 25 | 0% (72h) | 25 | [106] |
L. infantum (MHOM/BR/2009/ANC)4 |
96.6% (72h) | 25 | 0.4% (72h) | 25 | [106] |
L. infantum (MHOM/BR/2009/LCS)4 |
96.3% (72h) | 25 | 0% (72h) | 25 | [106] |
L. infantum (MHOM/BR/2009/VCF)4 |
0% (72h) | 25 | 0% (72h) | 25 | [106] |
L. donovani (MHOM/IN/80/DD8) | 50% 3 | 14.1 | 50% 3 | 51.89 | [63] |
L. donovani (MHOM/ET/1967/L82) |
94% (72h) | 25 | 62% (72h) | 25 | [106] |
L. mexicana (MHOM/VE/80/NR) |
50% 3 | 9.85 | 50% 3 | 42.08 | [63] |
L. mexicana (MHOM/ES/2002/LLM-1162) |
50% 3 | 12. 44 | 50% 3 | 40.67 | [63] |
L. mexicana (MHOM/BZ/82/BEL21) |
50% 3 | 10.25 | 50% 3 | 39.54 | [63] |
L. brazilensis (MHOM/BR/75/M2903) |
50% 3 | 14. 6 | 50% 3 | 36 | [63] |
L. braziliensis (MCAN/BR/1998/619) |
95% (72h) | 25 | 13% (72h) | 25 | [106] |
INHIBITON – Inhibition in relation to control. The number in brackets corresponds to the time when the inhibition was assayed.
Conc. – Concnetration of the inhibitor in µM.
The drugs were screened from 15 to 500 µM and the growth followed from 24 to 96 h. The inhibition observed was only marginal.
The drugs were screened at 12.5 and 25 µM and the growth compared to the control group after 72 h of incubation, no inhibition was observed.
The methodology described in ref [82] was elusive in relation to the time of incubation where the IC50 was calculated.
Strains isolated from HIV/Leishmania co-infected patient.